ゲノム編集（ゲノム工学）の世界市場：細胞株工学、動物遺伝子工学、植物遺伝子工学...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 29)
4.1 Lucrative Opportunities in the Global Genome Editing Market
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 33)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Application
5.2.2 By Product
5.2.3 By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increased R&D Expenditure and Growth of the Biotechnology and Pharmaceutical Industries
5.3.1.2 Increased Funding for Genomics Research
5.3.1.3 Technological Advancements
5.3.1.4 Increasing Demand for Synthetic Genes
5.3.1.5 Global Rise in Production of Genetically Modified Crops
5.3.2 Restraints
5.3.2.1 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
5.3.2.2 Adverse Public Perception Related to Genetic Research
5.3.3 Opportunities
5.3.3.1 Developing Countries
5.3.4 Challenges
5.3.4.1 Off-Target Effect of Crispr

6 Industry Insights (Page No. – 42)
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat From Substitutes
6.2.3 Bargaining Power of Buyers
6.2.4 Bargaining Power of Suppliers
6.2.5 Intensity of Rivalry
6.3 Strategic Benchmarking
6.4 Supply Chain Analysis
6.4.1 Key Influencers

7 Genome Editing Market, By Application (Page No. – 46)
7.1 Introduction
7.2 Cell Line Engineering
7.3 Animal Genetic Engineering
7.4 Plant Genetic Engineering
7.5 Other Applications

8 Genome Editing Market, By Technology (Page No. – 58)
8.1 Introduction
8.2 Crispr
8.3 Talen
8.4 ZFN
8.5 Antisense Technology
8.6 Other Technologies

9 Genome Editing Market, By End User (Page No. – 71)
9.1 Introduction
9.2 Biotechnology & Pharmaceutical Companies
9.3 Academic & Government Research Institutes
9.4 Contract Research Organizations

10 Geographic Analysis (Page No. – 81)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 120)
11.1 Overview
11.2 Leading Players in the Genome Editing Market
11.3 Competitive Situation and Trends
11.3.1 Agreements, Collaborations, and Partnerships
11.3.2 New Product and Service Launches
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Developments

12 Company Profiles (Page No. – 129)
12.1 Introduction
12.2 Thermo Fisher Scientific, Inc.
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Recent Developments
12.2.4 MnM View
12.2.4.1 Financial Analysis
12.2.4.2 Strategic Analysis
12.3 Horizon Discovery Group Plc
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Recent Developments
12.3.4 MnM View
12.3.4.1 Strategic Analysis
12.4 Sigma-Aldrich Corporation
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Recent Developments
12.4.4 MnM View
12.4.4.1 Financial Analysis
12.4.4.2 Strategic Analysis
12.5 Genscript USA Inc.
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Recent Developments
12.5.4 MnM View
12.5.4.1 Strategic Analysis
12.6 Sangamo Biosciences, Inc.
12.6.1 Business Overview
12.6.2 Product Portfolio
12.6.3 Recent Developments
12.6.4 MnM View
12.6.4.1 Strategic Analysis
12.7 Integrated Dna Technologies, Inc.
12.7.1 Business Overview
12.7.2 Product Portfolio
12.7.3 Recent Developments
12.7.4 Key Strategy
12.8 Lonza Group Ltd. (Switzerland)
12.8.1 Business Overview
12.8.2 Product Portfolio
12.9 New England Biolabs, Inc. (U.S.)
12.9.1 Business Overview
12.9.2 Product Portfolio
12.10 Origene Technologies, Inc. (U.S.)
12.10.1 Business Overview
12.10.2 Product Portfolio
12.10.3 Recent Developments
12.10.4 Key Strategy
12.11 Transposagen Biopharmaceuticals, Inc. (U.S.).
12.11.1 Business Overview
12.11.2 Product Portfolio
12.11.3 Recent Developments
12.11.4 Key Strategy

13 Appendix (Page No. – 154)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports